Infectious Disease Diagnostics Market
Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report by Product & Solution (Consumables, Instruments, and Software & Services), by Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing and Next-Generation Sequencing (NGS), DNA Microarray Technology, and Other Technologies) by Disease Type (Hepatitis, Human Immunodeficiency Virus (HIV), Hospital-Acquired Infections (HAIS), Human, Papillomavirus (HPV), Tuberculosis (TB), Influenza and Other Diseases) and by End-User (Hospital/Clinical Laboratories, Reference Laboratories, Academics/Research Institutes, and Others) Forecast Period (2022-2028)
Infectious disease diagnostics market is anticipated to grow at a significant CAGR of 5.9% during the forecast period. Infectious diseases are diseases caused by microscopic organisms including bacteria, viruses, parasites, and fungi. The organisms enter the body, multiply and cause symptoms ranging from mild to severe, including death. According to WHO, At least 169 severe hepatitis cases have been identified in children in an outbreak that involves 12 countries. Further in July 2022, WHO declared monkeypox a global health emergency. Climate change, rapid urbanization, globanisation, and the rising burden of infectious diseases and hospital acquired infections are primary factors driving the market growth of the infectious disease diagnostics market. The shift from centralized laboratories towards decentarlised point of care testing due to delay in results, high cost of tests, and late disease diagnosis is also an important factor anticipated to propel the demand for infectious disease diagnostics during the forecast period. Also, Several government-funded programs all over the globe are increasingly providing free screening and tests in order to increase awareness, accurately diagnose diseases, and minimize the chances of infection. Such initiatives are anticipated to drive the market growth in forecast period. For instance, in August 2022, the Australian Government funded $5.2 million to strengthen laboratory capacity for testing and diagnosis of COVID-19, HIV, malaria and tuberculosis in the Indo-Pacific region.
Segmental Outlook
The global infectious disease diagnostics market is segmented based on the product & solution, technology, disease type, and end-user. Based on the product & solution, the market is segmented into consumables, instruments, and software & services. Based on the technology, the market is sub-segmented into the immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing and next-generation sequencing (NGS), DNA microarray technology, and other technologies. Based on the disease type, the market is sub-segmented into the hepatitis, human immunodeficiency virus (HIV), hospital-acquired infections (HAIS), Human, papillomavirus (HPV), tuberculosis (TB), influenza and other diseases. Based on the End-User, the market is sub-segmented into the hospital/clinical laboratories, reference laboratories, academics/research institutes, and others. Among product & solution, the consumables sub-segment is anticipated to hold the dominant share in the market.
The Immunodiagnostics Segment is Expected to hold the Significant Share in the Global Infectious Disease Diagnostics Market during the Forecast Period.
Among technology, the immunodiagnostics segment isanticipated to dominate the overall infectious disease diagnostics market for the forecast period. The factors such as the Increasing use of immunoassays in infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about health and fitness, and reduced complications associated with the instruments are primary factors driving the growth of the immunodiagnostics sub-segment.
Regional Outlooks
The global infectious disease diagnostics market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). Among regions the North America region is anticipated to account for dominat share the market.
Global Infectious Disease Diagnostics Market Growth, by Region 2022-2028
The Asia-Pacific Regionis Expected to Hold the Considerable Share in the Global Infectious Disease Diagnostics Market during the Forecast Period.
Among regions, the Asia Pacific region is anticipated to register the fastest growth rate in market share. According to a report named "Infectious Diseases in the South-East Asia Region" by CDDEP, the South-East Asia region continues to bear a significant proportion of the communicable disease burden worldwide. South Asia has the third largest HIV epidemic globally and the highest TB burden, accounting for more than a quarter of the global burden. The second highest incidence of malaria, amongst all WHO regions, occurs in the southeast Asia region, and India bears the third-highest proportion of malaria cases globally. Thus the large population, growing prevelance of infectious diseases, and changing climatic conditions are some of the primary factors attributed to the growing share of the infectious disease diagnostics market in the region
Market Players Outlook
The major companies serving the global infectious disease diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Siemens Healthineers AG, Meridian Bioscience Inc., Grifols S.A., Sysmex Corp. , and others.. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2022, Abbott and WW International, Inc. announced a strategic partnership that will help people living with diabetes better understand and manage their diabetes and weight.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global infectious disease diagnostics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Abbott Laboratories
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. F. Hoffmann-La Roche Ltd.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. PerkinElmer, Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Siemens Healthineers AG
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Thermo Fisher Scientific Inc.
3.6.1. Overview
3.6.2. Financial Analysis
3.6.3. SWOT Analysis
3.6.4. Recent Developments
3.7. Key Strategy Analysis
4. Market Segmentation
4.1. Global Infectious Disease Diagnostics Market by Product & Solution
4.1.1. Consumables
4.1.2. Instruments
4.1.3. Software & Services
4.2. Global Infectious Disease Diagnostics Market by Technology
4.2.1. Immunodiagnostics
4.2.2. Clinical Microbiology
4.2.3. Polymerase Chain Reaction
4.2.4. Isothermal Nucleic Acid Amplification Technology
4.2.5. DNA Sequencing and Next-Generation Sequencing (NGS)
4.2.6. DNA Microarray Technology
4.2.7. Other technologies
4.2.8. (Other Technologies comprises of microscopy, hybridization, and loop-mediated isothermal amplification)
4.3. Global Infectious Disease Diagnostics Market by Disease Type
4.3.1. Hepatitis
4.3.2. Human Immunodeficiency Virus (HIV)
4.3.3. Human Papillomavirus (HPV)
4.3.4. Tuberculosis (TB)
4.3.5. Influenza
4.3.6. Other Diseases (measles, smallpox, mumps, typhoid fever, malaria, meningitis, Ebola virus disease, Lyme disease, coronavirus disease, and whooping cough)
4.4. Global Infectious Disease Diagnostics Market by End-User
4.4.1. Hospital/Clinical Laboratories
4.4.2. Reference Laboratories
4.4.3. Academics/Research Institutes
4.4.4. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Becton, Dickinson and Company
6.2. bioMérieux S.A.
6.3. Bio-Rad Laboratories, Inc.
6.4. Chembio Diagnostic Systems
6.5. Danaher Corp.
6.6. DiaSorin S.p.A.
6.7. ELITech Group
6.8. Genetic Signatures Ltd.
6.9. Grifols S.A.
6.10. Hologic, Inc.
6.11. Meridian Bioscience Inc.
6.12. Meril Life Sciences Pvt. Ltd.
6.13. Ortho Clinical Diagnostics Holdings plc
6.14. QIAGEN N.V.
6.15. Quidel Corp.
6.16. Seegene, Inc.
6.17. Sysmex Corp.
6.18. Trinity Biotech Plc.
1. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT & SOLUTION, 2021-2028 ($ MILLION)
2. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR CONSUMABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR SOFTWARE & SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
6. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR IMMUNODIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR CLINICAL MICROBIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR POLYMERASE CHAIN REACTION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR DNA SEQUENCING AND NEXT-GENERATION SEQUENCING (NGS) MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR DNA MICROARRAY TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR OTHER TECHNOLOGIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2021-2028 ($ MILLION)
14. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR HEPATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV) MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR HOSPITAL-ACQUIRED INFECTIONS (HAIS) MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR HUMAN PAPILLOMAVIRUS (HPV) MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR TUBERCULOSIS (TB) MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
19. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR INFLUENZA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
20. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR OTHER DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
21. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
22. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR HOSPITAL/CLINICAL LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
23. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR REFERENCE LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
24. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR ACADEMICS/RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
25. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
26. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
27. NORTH AMERICAN INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
28. NORTH AMERICAN INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT & SOLUTION, 2021-2028 ($ MILLION)
29. NORTH AMERICAN INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
30. NORTH AMERICAN INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2021-2028 ($ MILLION)
31. NORTH AMERICAN INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
32. EUROPEAN INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
33. EUROPEAN INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT & SOLUTION, 2021-2028 ($ MILLION)
34. EUROPEAN INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
35. EUROPEAN INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2021-2028 ($ MILLION)
36. EUROPEAN INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
37. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
38. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT & SOLUTION, 2021-2028 ($ MILLION)
39. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
40. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2021-2028 ($ MILLION)
41. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
42. REST OF THE WORLD INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
43. REST OF THE WORLD INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT & SOLUTION, 2021-2028 ($ MILLION)
44. REST OF THE WORLD INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
45. REST OF THE WORLD INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2021-2028 ($ MILLION)
46. REST OF THE WORLD INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE BY PRODUCT & SOLUTION, 2021 VS 2028 (%)
2. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR CONSUMABLES MARKET SHARE BY REGION, 2021 VS 2028 (%)
3. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR INSTRUMENTS MARKET SHARE BY REGION, 2021 VS 2028 (%)
4. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR SOFTWARE & SERVICES MARKET SHARE BY REGION, 2021 VS 2028 (%)
5. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE BY TECHNOLOGY, 2021 VS 2028 (%)
6. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR IMMUNODIAGNOSTICS MARKET SHARE BY REGION, 2021 VS 2028 (%)
7. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR CLINICAL MICROBIOLOGY MARKET SHARE BY REGION, 2021 VS 2028 (%)
8. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR POLYMERASE CHAIN REACTION MARKET SHARE BY REGION, 2021 VS 2028 (%)
9. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE BY REGION, 2021 VS 2028 (%)
10. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR DNA SEQUENCING AND NEXT-GENERATION SEQUENCING (NGS) MARKET SHARE BY REGION, 2021 VS 2028 (%)
11. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR DNA MICROARRAY TECHNOLOGY MARKET SHARE BY REGION, 2021 VS 2028 (%)
12. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR OTHER TECHNOLOGIES MARKET SHARE BY REGION, 2021 VS 2028 (%)
13. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE BY DISEASE TYPE, 2021 VS 2028 (%)
14. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR HEPATITIS MARKET SHARE BY REGION, 2021 VS 2028 (%)
15. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV) MARKET SHARE BY REGION, 2021 VS 2028 (%)
16. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR HOSPITAL-ACQUIRED INFECTIONS (HAIS) MARKET SHARE BY REGION, 2021 VS 2028 (%)
17. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR HUMAN PAPILLOMAVIRUS (HPV) MARKET SHARE BY REGION, 2021 VS 2028 (%)
18. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR TUBERCULOSIS (TB) MARKET SHARE BY REGION, 2021 VS 2028 (%)
19. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR INFLUENZA MARKET SHARE BY REGION, 2021 VS 2028 (%)
20. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR OTHERS MARKET SHARE BY REGION, 2021 VS 2028 (%)
21. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
22. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR HOSPITAL/CLINICAL LABORATORIES MARKET SHARE BY REGION, 2021 VS 2028 (%)
23. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR REFERENCE LABORATORIES MARKET SHARE BY REGION, 2021 VS 2028 (%)
24. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR ACADEMICS/RESEARCH INSTITUTES MARKET SHARE BY REGION, 2021 VS 2028 (%)
25. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS FOR OTHERS MARKET SHARE BY REGION, 2021 VS 2028 (%)
26. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE BY REGION, 2021 VS 2028 (%)
27. US INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
28. CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
29. UK INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
30. FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
31. GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
32. ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
33. SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
34. REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
35. INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
36. CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
37. JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
38. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
39. REST OF ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
40. REST OF THE WORLD INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
